Recent evidence indicates that H19 enhances invasion and metastasis in bladder cancer [13, 14], glioma [15], osteosarcoma [16], acute myeloid leukemia [17], breast cancer [18, 19], non-small cell lung cancer [20], gastric cancer [21], and pancreatic cancer [22], but suppresses the aggressiveness of hepatocellular carcinoma [23] and prostate cancer [24]. The gene discussed is H19; the disease is breast carcinoma.